Second‐trimester maternal serum markers and placenta accreta
暂无分享,去创建一个
J. Oury | L. Salomon | F. Goffinet | L. Sentilhes | F. Muller | S. Dreux | ABA Study Group
[1] M. Edelson,et al. Utility of ultrasound and MRI in prenatal diagnosis of placenta accreta: a pilot study. , 2011, AJR. American journal of roentgenology.
[2] Yvonne W. Cheng,et al. Diagnosis and morbidity of placenta accreta , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[3] L. Salomon,et al. Screening for adverse pregnancy outcome at early gestational age. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[4] A. Benachi,et al. Maternal Outcome After Conservative Treatment of Placenta Accreta , 2010, Obstetrics and gynecology.
[5] K. Benirschke,et al. Effect of Predelivery Diagnosis in 99 Consecutive Cases of Placenta Accreta , 2010, Obstetrics and gynecology.
[6] J. Hibbard,et al. Abnormal placentation: twenty-year analysis. , 2005, American journal of obstetrics and gynecology.
[7] T. Hung,et al. Risk factors for placenta accreta. , 1999 .
[8] R. Tamura,et al. Placenta Accreta is Associated With Elevated Maternal Serum Alpha-Fetoprotein , 1993, Obstetrics and gynecology.
[9] B. Benacerraf,et al. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. , 1992, Obstetrics and gynecology.
[10] J. O'Brien. Placenta previa, placenta accreta, and vasa previa. , 2007, Obstetrics and gynecology.